RESEARCH PROGRESS IN INDIVIDUALIZED DRUG SCREENING TECHNOLOGY FOR PATIENTS WITH TUMORS
In China, the incidence of tumors is increasing year by year, with the number of patients with new tumors ranking first in the world. Currently, tumors are usually treated with surgery combined with radiotherapy, chemotherapy, targeted therapy, or immunotherapy. However, individuals with tumors vary...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of Journal of Precision Medicine
2023-12-01
|
| Series: | 精准医学杂志 |
| Subjects: | |
| Online Access: | https://jpmed.qdu.edu.cn/fileup/2096-529X/PDF/1701928517431-1544199128.pdf |
| _version_ | 1797265478248300544 |
|---|---|
| author | WU Xiao-xiao, LIU Meiyou, PENG Li, CHENG Lianghua, WANG Fan, WANG Jingwen, JIA Yanyan |
| author_facet | WU Xiao-xiao, LIU Meiyou, PENG Li, CHENG Lianghua, WANG Fan, WANG Jingwen, JIA Yanyan |
| author_sort | WU Xiao-xiao, LIU Meiyou, PENG Li, CHENG Lianghua, WANG Fan, WANG Jingwen, JIA Yanyan |
| collection | DOAJ |
| description | In China, the incidence of tumors is increasing year by year, with the number of patients with new tumors ranking first in the world. Currently, tumors are usually treated with surgery combined with radiotherapy, chemotherapy, targeted therapy, or immunotherapy. However, individuals with tumors vary substantially in response to chemotherapeutic drugs. Therefore, selecting the drugs that patients are most sensitive to through the in vitro drug sensitivity screening technology is of great importance to guide personalized drug treatment of patients with tumors. Currently, there are various techniques for personalized anti-tumor drug screening, each with its own advantages and disadvantages. This article reviews the application progress on several commonly used techniques, with the aim to provide a reference for the selection of personalized anti-tumor drug screening techno-logy. |
| first_indexed | 2024-04-25T00:45:26Z |
| format | Article |
| id | doaj.art-b63ef5799d424f12b2c3f758378161b4 |
| institution | Directory Open Access Journal |
| issn | 2096-529X |
| language | zho |
| last_indexed | 2024-04-25T00:45:26Z |
| publishDate | 2023-12-01 |
| publisher | Editorial Office of Journal of Precision Medicine |
| record_format | Article |
| series | 精准医学杂志 |
| spelling | doaj.art-b63ef5799d424f12b2c3f758378161b42024-03-12T06:31:42ZzhoEditorial Office of Journal of Precision Medicine精准医学杂志2096-529X2023-12-0138655655910.13362/j.jpmed.202306022RESEARCH PROGRESS IN INDIVIDUALIZED DRUG SCREENING TECHNOLOGY FOR PATIENTS WITH TUMORSWU Xiao-xiao, LIU Meiyou, PENG Li, CHENG Lianghua, WANG Fan, WANG Jingwen, JIA Yanyan0Department of Pharmacy, First Affiliated Hospital of Air Force Military Medical University of Chinese People’s Liberation Army, Xi'an 710000, ChinaIn China, the incidence of tumors is increasing year by year, with the number of patients with new tumors ranking first in the world. Currently, tumors are usually treated with surgery combined with radiotherapy, chemotherapy, targeted therapy, or immunotherapy. However, individuals with tumors vary substantially in response to chemotherapeutic drugs. Therefore, selecting the drugs that patients are most sensitive to through the in vitro drug sensitivity screening technology is of great importance to guide personalized drug treatment of patients with tumors. Currently, there are various techniques for personalized anti-tumor drug screening, each with its own advantages and disadvantages. This article reviews the application progress on several commonly used techniques, with the aim to provide a reference for the selection of personalized anti-tumor drug screening techno-logy.https://jpmed.qdu.edu.cn/fileup/2096-529X/PDF/1701928517431-1544199128.pdfneoplasms|drug screening assays, antitumor|genome aequencing|organoids|xenograft model antitumor assays|precision medicine|disease models, animal|review |
| spellingShingle | WU Xiao-xiao, LIU Meiyou, PENG Li, CHENG Lianghua, WANG Fan, WANG Jingwen, JIA Yanyan RESEARCH PROGRESS IN INDIVIDUALIZED DRUG SCREENING TECHNOLOGY FOR PATIENTS WITH TUMORS 精准医学杂志 neoplasms|drug screening assays, antitumor|genome aequencing|organoids|xenograft model antitumor assays|precision medicine|disease models, animal|review |
| title | RESEARCH PROGRESS IN INDIVIDUALIZED DRUG SCREENING TECHNOLOGY FOR PATIENTS WITH TUMORS |
| title_full | RESEARCH PROGRESS IN INDIVIDUALIZED DRUG SCREENING TECHNOLOGY FOR PATIENTS WITH TUMORS |
| title_fullStr | RESEARCH PROGRESS IN INDIVIDUALIZED DRUG SCREENING TECHNOLOGY FOR PATIENTS WITH TUMORS |
| title_full_unstemmed | RESEARCH PROGRESS IN INDIVIDUALIZED DRUG SCREENING TECHNOLOGY FOR PATIENTS WITH TUMORS |
| title_short | RESEARCH PROGRESS IN INDIVIDUALIZED DRUG SCREENING TECHNOLOGY FOR PATIENTS WITH TUMORS |
| title_sort | research progress in individualized drug screening technology for patients with tumors |
| topic | neoplasms|drug screening assays, antitumor|genome aequencing|organoids|xenograft model antitumor assays|precision medicine|disease models, animal|review |
| url | https://jpmed.qdu.edu.cn/fileup/2096-529X/PDF/1701928517431-1544199128.pdf |
| work_keys_str_mv | AT wuxiaoxiaoliumeiyoupenglichenglianghuawangfanwangjingwenjiayanyan researchprogressinindividualizeddrugscreeningtechnologyforpatientswithtumors |